^
KRAS mutation
Juvenile Myelomonocytic Leukemia
decitabine
Sensitive: C4 – Case Studies
ETV6-FLT3 fusion
Juvenile Myelomonocytic Leukemia
gilteritinib
Sensitive: C4 – Case Studies
SETBP1 mutation + NRAS mutation
Juvenile Myelomonocytic Leukemia
trametinib
Sensitive: D – Preclinical